AzTrials
AzTrials

StrokeNCT07773038

Digital Health Literacy and Social Participation in Individuals With Hemiplegia

An observational study of Stroke and Hemiplegia, run by Afyonkarahisar Health Sciences University at 1 site in Turkey (Türkiye).

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

This cross-sectional observational study aims to investigate the association between digital health literacy and social participation in individuals with hemiplegia after stroke. A total of 250 adults with a history of stroke at least 6 months previously will be included. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Stroke, Hemiplegia
How many people
250 participants
Where
1 siteTurkey (Türkiye)
Study dates
28 Aug 2026to 28 Feb 2027
How long will I take part?
1 Day
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: The study population will consist of adults with hemiplegia following stroke who receive care at the Physical Medicine and Rehabilitation outpatient clinic, inpatient service, or rehabilitation unit of Afyonkarahisar Health Sciences University. Eligible participants will have a history of stroke at least 6 months before enrollment, be able to communicate and complete the study assessments, and have a Mini-Mental State Examination score of 24 or higher. Both female and male participants will be included.

Who may be able to join

  • Age 18 years or older Diagnosis of hemiplegia following stroke History of stroke at least 6 months before enrollment Ability to communicate sufficiently to complete the study assessments Mini-Mental State Examination score of 24 or higher Ability and willingness to provide written informed consent

Who cannot join

  • Severe aphasia preventing completion of the assessments Advanced cognitive impairment Severe psychiatric disorder that may interfere with participation or completion of the assessments Visual or hearing impairment that prevents completion of the questionnaires

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Turkey (Türkiye)1 site
  • Afyonkarahisar Health Sciences University

    Afyonkarahisar, 03032

    Ersin Beştaş, MD, +90 506 889 32 66, ersinbestas26@gmail.com

    Ersin Beştaş, MD, ersinbestas26@gmail.com

Other trials in Turkey (Türkiye)

About this study

Official title: The Association Between Digital Health Literacy and Social Participation in Individuals With Hemiplegia: A Cross-Sectional Study

This cross-sectional observational study aims to investigate the association between digital health literacy and social participation in individuals with hemiplegia after stroke. A total of 250 adults with a history of stroke at least 6 months previously will be included. Digital health literacy will be assessed using the eHealth Literacy Scale (eHEALS), and social participation will be assessed using the Reintegration to Normal Living Index (RNLI). The secondary aim is to examine the associations of digital health literacy with anxiety and depression, functional independence, and fatigue.

Read the detailed description

Stroke-related hemiplegia may affect not only motor function and independence in activities of daily living but also individuals' ability to participate in family, social, and community life. With the increasing use of online health information, mobile health applications, and electronic health services, digital health literacy may play an important role in access to health information, self-management, and engagement in rehabilitation.

This study is designed as a single-center, cross-sectional observational study. It will include 250 adults aged 18 years or older who have hemiplegia following a stroke that occurred at least 6 months previously. Participants must be able to communicate, provide written informed consent, and have a Mini-Mental State Examination score of 24 or higher.

Sociodemographic and clinical characteristics, including age, sex, education level, employment status, stroke duration, affected side, assistive device use, functional ambulation level, smartphone use, internet use, and use of electronic health services, will be recorded.

Digital health literacy will be evaluated using the eHealth Literacy Scale (eHEALS). Social participation, the primary outcome of the study, will be evaluated using the Reintegration to Normal Living Index (RNLI). Anxiety and depressive symptoms will be assessed using the Hospital Anxiety and Depression Scale (HADS), functional independence using the Barthel Index, fatigue using the Fatigue Severity Scale (FSS), and cognitive status using the Mini-Mental State Examination.

The primary analysis will examine the association between the eHEALS total score and the RNLI total score. Multiple linear regression analysis will be used to investigate whether digital health literacy is independently associated with social participation after accounting for relevant sociodemographic and clinical variables.

Conditions
Stroke, Hemiplegia
Keywords
Digital Health Literacy, Social Participation, Stroke Rehabilitation, Hemiplegia, eHealth Literacy, Community Reintegration, Functional Independence
Medical subject headings
Stroke, Hemiplegia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT07773038
Study groupRoleWhat they receive
Individuals With Post-Stroke HemiplegiaAdults with hemiplegia following stroke who meet the eligibility criteria will undergo a single cross-sectional assessment of digital health literacy, social participation, anxiety and depressive symptoms, functional independence, fatigue, and cognitive status. No study-specific intervention will be administered.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Social Participation Assessed by the Reintegration to Normal Living Index

    Social participation will be assessed using the Reintegration to Normal Living Index (RNLI). The RNLI consists of 11 items evaluating reintegration into daily activities, family roles, social relationships, and community life. The total score ranges from 0 to 110, with higher scores indicating better reintegration and social participation.

    Measured: At the single study assessment (Day 1)

Secondary outcomes (5)
  1. Digital Health Literacy Assessed by the eHealth Literacy Scale

    Digital health literacy will be assessed using the eHealth Literacy Scale (eHEALS). The scale consists of 8 items rated on a 5-point Likert scale. The total score ranges from 8 to 40, with higher scores indicating greater perceived digital health literacy.

    Measured: At the single study assessment (Day 1)

  2. Anxiety Symptoms Assessed by the Hospital Anxiety and Depression Scale

    Anxiety symptoms will be assessed using the 7-item anxiety subscale of the Hospital Anxiety and Depression Scale (HADS-A). The subscale score ranges from 0 to 21, with higher scores indicating greater anxiety symptom severity.

    Measured: At the single study assessment (Day 1)

  3. Depressive Symptoms Assessed by the Hospital Anxiety and Depression Scale

    Depressive symptoms will be assessed using the 7-item depression subscale of the Hospital Anxiety and Depression Scale (HADS-D). The subscale score ranges from 0 to 21, with higher scores indicating greater depressive symptom severity.

    Measured: At the single study assessment (Day 1)

  4. Functional Independence Assessed by the Barthel Index

    Functional independence in activities of daily living will be assessed using the Barthel Index. The total score ranges from 0 to 100, with higher scores indicating greater functional independence.

    Measured: At the single study assessment (Day 1)

  5. Fatigue Assessed by the Fatigue Severity Scale

    Fatigue will be assessed using the Fatigue Severity Scale (FSS), which consists of 9 items rated from 1 to 7. The mean score ranges from 1 to 7, with higher scores indicating greater fatigue severity.

    Measured: At the single study assessment (Day 1)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 Aug 2026
  2. Study start28 Aug 2026 (estimated)
  3. Primary completion28 Feb 2027 (estimated)
  4. Study completion28 Feb 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Cross-sectional
Enrolment
250 participants (estimated)
Target duration
1 Day
IDs, dates and publications
ClinicalTrials.gov ID
NCT07773038
Sponsor's protocol ID
AFSU-FTR-DHLSP-2026
Status last verified
Aug 2026
First submitted
14 Aug 2026
Last updated
19 Aug 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Stroke and Hemiplegia, run by Afyonkarahisar Health Sciences University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 19 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Ersin Beştaş, MD (+90 506 889 32 66, ersinbestas26@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Social Participation Assessed by the Reintegration to Normal Living Index (time frame: At the single study assessment (Day 1)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Aug 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in